Home » ETF » IBDD

IBDD - iShares iBonds Mar 2023 Term Corporate ETF

Stock Price: $27.17 USD -0.03 (-0.09%)
Updated Apr 21, 2021 4:00 PM EDT - Market closed
Assets $73.25M
NAV $27.13
Expense Ratio 0.10%
PE Ratio n/a
Beta (5Y) 0.07
Dividend (ttm) $0.65
Dividend Yield 2.38%
Ex-Dividend Date Apr 1, 2021
1-Year Return -
Trading Day April 21
Last Price $27.17
Previous Close $27.20
Change ($) -0.03
Change (%) -0.09%
Day's Open 27.09
Day's Range 27.09 - 27.34
Day's Volume 9,835
52-Week Range 25.62 - 28.39

Fund Description

The investment seeks to track the investment results of the Bloomberg Barclays 2023 Maturity Corporate Index which composed of U.S. dollar-denominated, investment-grade corporate bonds maturing after March 31, 2022 and before April 1, 2023. The fund generally will invest at least 90% of its assets in the component securities (including indirect investments through an underlying fund) of the underlying index, and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index, but which BFA believes will help the fund track the underlying index.

Asset Class
Portfolio-Multi Asset
Sector
Bonds
Region
North America
Inception Date
Jul 9, 2013
Exchange
NYSEARCA
Ticker Symbol
IBDD
Index Tracked
Bloomberg Barclays 2023 Maturity Corporate Index

Top 10 Holdings

8.42% of assets
NameSymbolWeight
BlackRock Cash Funds Treasury SL AgencyXTSLA1.81%
Bank of America Corporation 3.3%n/a0.96%
AbbVie Inc. 2.9%n/a0.78%
Goldman Sachs Group, Inc. 3%n/a0.72%
Oracle Corporation 2.5%n/a0.71%
Goldman Sachs Group, Inc. 3.63%n/a0.70%
JPMorgan Chase & Co. 3.25%n/a0.70%
Morgan Stanley 3.75%n/a0.70%
Oracle Corporation 2.5%n/a0.68%
Morgan Stanley 2.75%n/a0.67%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Apr 1, 2021$0.048Apr 8, 2021
Mar 1, 2021$0.05Mar 5, 2021
Feb 1, 2021$0.049Feb 5, 2021
Dec 17, 2020$0.061Dec 23, 2020
Nov 2, 2020$0.051Nov 6, 2020
Oct 1, 2020$0.053Oct 7, 2020
Full Dividend History

News

There are no news available yet.